Niveau de preuve du suivi thérapeutique pharmacologique du 5-fluorouracile au décours de son administration dans le traitement des cancers des voies aérodigestives supérieures et du cancer colorectal-Reference-Cited by-同舟云学术

Niveau de preuve du suivi thérapeutique pharmacologique du 5-fluorouracile au décours de son administration dans le traitement des cancers des voies aérodigestives supérieures et du cancer colorectal

Published:2010-05 Issue:3 Volume:65 Page:171-176
ISSN:0040-5957
Container-title:Therapies
language:fr
Short-container-title:Therapies

Author:

Boisdron-Celle Michèle,Le Guellec Chantal

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference36 articles.

1. Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer;Thyss;Cancer Chemother Pharmacol,1986

2. 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer;Santini;Br J Cancer,1989

3. Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer;Vokes;J Clin Oncol,1996

4. Relationship between fluorouracil systemic exposure and tumor response and patient survival;Milano;J Clin Oncol,1994

5. Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results;Fety;Anticancer Res,1994

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular relation between biological stress and carcinogenesis;Molecular Biology Reports;2022-05-24

2. How can we best monitor 5-FU administration to maximize benefit to risk ratio?;Expert Opinion on Drug Metabolism & Toxicology;2018-11-23

3. Suivi thérapeutique pharmacologique du 5-fluorouracile : mise au point et recommandations du groupe STP-PT de la SFPT et du GPCO-Unicancer;Bulletin du Cancer;2018-09

4. Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs;Annales de biologie clinique;2014-09

5. LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients;Biomedical Chromatography;2012-03-27